Strategic Investment Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$110K Buy
4,555
+45
+1% +$1.18K 0.03% 199
2026
Q1
$127K Sell
4,510
-347
-7% -$9.24K 0.03% 178
2025
Q4
$121K Buy
4,857
+336
+7% +$8.47K 0.03% 166
2025
Q3
$115K Buy
4,521
+482
+12% +$11.9K 0.03% 165
2025
Q2
$97.9K Sell
4,039
-261
-6% -$6.09K 0.03% 164
2025
Q1
$109K Sell
4,300
-2,399
-36% -$62.8K 0.03% 130
2024
Q4
$179K Buy
6,699
+2,477
+59% +$67.2K 0.06% 108
2024
Q3
$122K Buy
4,222
+10
+0.2% +$292 0.04% 125
2024
Q2
$170K Buy
+4,212
New +$116K 0.05% 100
2023
Q4
$189K Sell
6,551
-242,264
-97% -$7.32M 0.03% 210
2023
Q3
$8.8M Buy
248,815
+244,907
+6,267% +$8.66M 0.11% 101
2023
Q2
$148K Sell
3,908
-2,024
-34% -$78.8K 0.03% 170
2023
Q1
$242K Buy
5,932
+30
+0.5% +$1.3K 0.05% 163
2022
Q4
$262K Buy
+5,902
New +$283K 0.13% 79

Other funds holding PFE

Strategic Investment Solutions's PFE Position: Q2 2026 in Review

Strategic Investment Solutions increased its Pfizer (PFE) stake by 1% in Q2 2026, buying an estimated $1.18K and bringing the position to 4,555 shares worth $110K. The position accounts for 0.03% of the portfolio, ranked #199.

Strategic Investment Solutions first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $8.8M in Q3 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Strategic Investment Solutions held 4,555 shares of Pfizer worth $110K as of Q2 2026.
  • Strategic Investment Solutions bought 45 Pfizer shares in Q2 2026, an estimated $1.18K.
  • Pfizer made up 0.03% of Strategic Investment Solutions's portfolio in Q2 2026, its #199 holding.
  • Strategic Investment Solutions first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
  • Strategic Investment Solutions's Pfizer position peaked at $8.8M in Q3 2023.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.